CapsoVision to Participate in the 4th Annual ROTH Healthcare Opportunities Conference

Rhea-AI Summary

CapsoVision (NASDAQ: CV), a medical technology company specializing in advanced imaging and AI-enabled capsule endoscopy solutions, has announced its participation in the upcoming 4th Annual ROTH Healthcare Opportunities Conference.

The conference will take place on October 9, 2025, in New York, NY. Company representatives Johnny Wang, President and CEO, and Doug Atkinson, Head of Global Sales, will be available for one-on-one meetings with interested parties during the event.

News Market Reaction – CV

+0.66%

+0.66% Session close to close

In the Sep 26 session, CV gained 0.66%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SARATOGA, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that Johnny Wang, President and Chief Executive Officer, and Doug Atkinson, Head of Global Sales, will participate in the 4th Annual ROTH Healthcare Opportunities Conference, taking place on Thursday, October 9, 2025, in New York, NY.

If you are interested in arranging a one-on-one meeting with CapsoVision’s management team at the conference, please contact your ROTH representative or reach out to the company directly at Investors@CapsoVision.com.

About CapsoVision

CapsoVision is a commercial-stage medical technology company focused on developing advanced imaging and AI-enabled solutions to transform the detection and diagnosis of gastrointestinal diseases. Its flagship product, CapsoCam Plus®, is a wire-free, panoramic capsule endoscope that enables high-resolution visualization of the small bowel and supports cloud-based or direct capsule video retrieval. The Company’s next pipeline product, CapsoCam Colon with enhanced AI, is designed to enable non-invasive colon imaging and polyp detection. With a proprietary platform targeted to expand across multiple GI indications, including esophageal and pancreatic disorders, CapsoVision is advancing a new era in capsule-based diagnostics. For more information on CapsoVision, please visit www.capsovision.com.

Investor Relations Contact
Leigh Salvo
New Street Investor Relations
Investors@CapsoVision.com

Media Contact
Leslie Strickler and Paul Spicer
Être Communications
leslies@etrecommunications.com | (804) 240-0807
pauls@etrecommunications.com | (804) 503-9231

FAQ

When is CapsoVision (CV) presenting at the ROTH Healthcare Conference 2025?

CapsoVision will participate in the conference on Thursday, October 9, 2025 in New York, NY.

Who will represent CapsoVision at the ROTH Healthcare Conference?

Johnny Wang, President and CEO, and Doug Atkinson, Head of Global Sales, will represent CapsoVision at the conference.

How can investors schedule meetings with CapsoVision management at the ROTH conference?

Investors can arrange meetings by contacting their ROTH representative or reaching out directly to the company at Investors@CapsoVision.com.

What does CapsoVision (CV) company do?

CapsoVision is a commercial-stage medical technology company that develops advanced imaging and AI-enabled capsule endoscopy solutions.